What does minimal residual disease mean in AL amyloidosis?

Paolo Milani, Giampaolo Merlini, Giovanni Palladini

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Expert Opinion on Orphan Drugs
DOIs	https://doi.org/10.1080/21678707.2018.1549482
Publication status	Accepted/In press - Jan 1 2018

Keywords

Amyloidosis
minimal residual disease
prognosis
response

ASJC Scopus subject areas

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Health Policy
Pharmacology (medical)

Access to Document

10.1080/21678707.2018.1549482

Cite this

@article{599d9d8df539485d9942e0ceb473193f,

title = "What does minimal residual disease mean in AL amyloidosis?",

keywords = "Amyloidosis, minimal residual disease, prognosis, response",

author = "Paolo Milani and Giampaolo Merlini and Giovanni Palladini",

year = "2018",

month = jan,

day = "1",

doi = "10.1080/21678707.2018.1549482",

language = "English",

journal = "Expert Opinion on Orphan Drugs",

issn = "2167-8707",

publisher = "Informa Healthcare",

}

TY - JOUR

T1 - What does minimal residual disease mean in AL amyloidosis?

AU - Milani, Paolo

AU - Merlini, Giampaolo

AU - Palladini, Giovanni

PY - 2018/1/1

Y1 - 2018/1/1

KW - Amyloidosis

KW - minimal residual disease

KW - prognosis

KW - response

UR - http://www.scopus.com/inward/record.url?scp=85057323540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057323540&partnerID=8YFLogxK

U2 - 10.1080/21678707.2018.1549482

DO - 10.1080/21678707.2018.1549482

M3 - Article

AN - SCOPUS:85057323540

JO - Expert Opinion on Orphan Drugs

JF - Expert Opinion on Orphan Drugs

SN - 2167-8707

ER -